# Role of Citicoline in Treatment of Neonates With Hypoxic Ischemic Encephalopathy

> **NCT06522581** · PHASE1 · RECRUITING · sponsor: **Armed Forces Hospital, Pakistan** · enrollment: 200 (estimated)

## Conditions studied

- Hypoxic Ischemic Encephalopathy of Newborn

## Interventions

- **DRUG:** Citicoline Sodium

## Key facts

- **NCT ID:** NCT06522581
- **Lead sponsor:** Armed Forces Hospital, Pakistan
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-01-01
- **Primary completion:** 2025-01-01
- **Final completion:** 2025-01-01
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2024-08-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06522581

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06522581, "Role of Citicoline in Treatment of Neonates With Hypoxic Ischemic Encephalopathy". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT06522581. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*